Endocrinología

Statins Decrease the Risk of Orbitopathy in Newly Diagnosed Patients with Graves Disease

The Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 5, May 2021, Pages 1325–1332, https://doi.org/10.1210/clinem/dgab070

Published: 09 February 2021

 

Abstract

Context/objective

The aim of this study was to examine the effect of statins and other lipid-lowering agents on the development of Graves orbitopathy (GO) in patients with newly diagnosed Graves disease (GD).

Methods

Clinical, Diagnostic, and Therapeutic Aspects of Growth Hormone Deficiency During the Transition Period: Review of the Literature

Matteo Spaziani, Chiara Tarantino, Natascia Tahani, Daniele Gianfrilli, Emilia Sbardella, Andrea M Isidori, Andrea Lenzi, Antonio F Radicioni

Frontiers in Endocrinology 2021, 12: 634288

doi: 10.3389/fendo.2021.634288

18F-Fluorocholine Positron Emission Tomography/Computed Tomography Is a Highly Sensitive but Poorly Specific Tool for Identifying Malignancy in Thyroid Nodules with Indeterminate Cytology: The Chocolate Study

Published Online:23 Dec 2020

https://doi.org/10.1089/thy.2020.0555

 

Abstract

Background: Refining the risk of malignancy in patients presenting with thyroid nodules with indeterminate cytology (IC) is a critical challenge. We investigated the performances of 18F-fluorocholine (FCH) positron emission tomography/computed tomography (PET/CT) to predict malignancy.